Stefan Mullner
31Patents
12h-index
47Co-inventors
81Inventor score
Filing activity: Aug 25, 1989 → Jan 12, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5430110A | Polyvinylamine derivatives having hydrophilic centers, processes for their preparation and the use of the compounds as a medicament, active compound carrier and foodstuff auxiliary | Human Necessities | 75 | Expired |
| US5428112A | Crosslinked, nitrogen-containing vinyl copolymers, processes for their preparation and the use of these compounds | Chemistry; Metallurgy | 45 | Expired |
| US5976811A | Antibodies for the selective immunological determination of bile acids in biological matrices | Emerging Cross-Sectional Technologies | 42 | Expired |
| US5250524A | Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals | Chemistry; Metallurgy | 40 | Expired |
| US5430116A | Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 28 | Expired |
| US5780592A | Compositions comprising lipoproteins and crotonamide derivatives | Human Necessities | 25 | Expired |
| US6265588A | Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics | Physics | 25 | Expired |
| US6140365A | Preparation of microorganisms comprising omega-3-fatty acid for use as a prophylactic or therapeutic agent against parasitic diseases of animals | Human Necessities | 24 | Expired |
| US5624903A | Phosphoinositol-glycan-peptide with insulin-like action | Human Necessities | 23 | Expired |
| US5750679A | Process for obtaining pharmacologically active compounds from complex mixtures of substances | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6337325B1 | Combined preparation for the therapy of immune diseases | Human Necessities | 14 | Expired |
| US4948481A | Process and device for the electrophoretic separation, purification and concentration of charged or polarizable macromolecules | Physics | 13 | Expired |
| US5401498A | Pharmaceuticals comprising polyhydroxymethylene derivatives, process for their preparation and use | Human Necessities | 12 | Expired |
| US5268272A | Complexes containing glycosyl-phosphatidylinositol proteins and cholanic acid derivatives, a process for their preparation and their use | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5990103A | Combination preparation for use in immunological diseases | Human Necessities | 11 | Expired |
| US5981536A | Use of xanthine derivatives for the modulation of apoptosis | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5856330A | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6589785B1 | Disrupting cells and/or tissue in solid state in presence of solid denaturing substance | Chemistry; Metallurgy | 5 | Expired |
| US6011051A | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5728686A | Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5977151A | Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics | Physics | 4 | Expired |
| US6121479A | Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics | Physics | 4 | Expired |
| US5461035A | Short peptides with insulin activity | Human Necessities | 1 | Expired |
| US5714138A | Polyaspartamide derivatives as adsorbents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 1 | Expired |
| US5514599A | Antibodies against highly conserved amino acid sequences of insulin a process for the preparation of these antibodies and the use thereof in immunoassays | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.